1-3 of 3
Stefan O Schoenland, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Identification of Baseline Characteristics That Predict Good Outcome of Allogeneic Hematopoietic Cell Transplantation in Young Chronic Lymphocytic Leukemia Patients - a Retrospective Analysis from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation.

Michel van Gelder, MD PhD, Dimitris Ziagkos, Liesbeth C de Wreede, PhD, Anja van Biezen, Peter Dreger, MD, Martin Gramatzki, MD, Matthias Stelljes, Niels Smedegaard Andersen, Nicolaas PM Schaap, MD, Antonin Vitek, Dietrich Beelen, MD, Liisa Volin, MD PhD, Jürgen Finke, Jakob R Passweg, MD, Arnold Ganser, Maciej J Machaczka, MD, Julio Delgado, MD, William Krüger, Edgar Faber, Gerard Socie, Pavel Jindra, MD PhD, Boris V Afanasyev, Professor, Matthias Theobald, MD PhD, Yves Chalandon, MD, Anja Henseler, Stefan O. Schoenland, MD, Kroger Nicolaus, Johannes Schetelig, MD MSc
Journal: Blood
Blood (2016) 128 (22): 522.
https://doi.org/10.1182/blood.V128.22.522.522
Published: 2016
Journal Articles

HOVON 104; Results of First 25 Patients from a Multicenter, Multinational, Prospective Phase II Study of Bortezomib Based Induction Treatment Followed By Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Al Amyloidosis

Monique Minnema, Kazem Nasserinejad, MA, Bouke Hazenberg, MD PhD, Ute Hegenbart, Lucien Noens, MD PhD, Paula F. Ypma, MD, Sonja Zweegman, MD PhD, Lidwine Winnifred Tick, MD PhD, Annemiek Broijl, MD PhD, Harry R. Koene, MD PhD, Gerard M.J. Bos, MD PhD, Pieter Sonneveld, MD PhD, Stefan O. Schoenland, MD
Journal: Blood
Blood (2016) 128 (22): 4628.
https://doi.org/10.1182/blood.V128.22.4628.4628
Published: 2016
Journal Articles

Long-Term Outcome of a Phase 1 Study of the Investigational Oral Proteasome Inhibitor (PI) Ixazomib at the Recommended Phase 3 Dose (RP3D) in Patients (Pts) with Relapsed or Refractory Systemic Light-Chain (AL) Amyloidosis (RRAL)

Giampaolo Merlini, MD, Vaishali Sanchorawala, MD, Zonder A Jeffrey, MD, Vishal Kukreti, MD FRCPC, Stefan O Schoenland, MD, Arnaud Jaccard, MD, Angela Dispenzieri, MD, Adam D. Cohen, MD, Deborah Berg, RN, MSN, Zheng Yuan, PhD, Ai-Min Hui, MD PhD, Palladini Giovanni, MD PhD, Raymond L. Comenzo, MD
Journal: Blood
Blood (2014) 124 (21): 3450.
https://doi.org/10.1182/blood.V124.21.3450.3450
Published: 2014